entacapone

Ukraine

Drugs containing this active substance

  • CONFUNDUS® TRIO

    The drug is used for the treatment of Parkinson's disease, specifically to alleviate motor impairments (instability) caused by the ineffectiveness of previous medication dosages.

    Form: tablets, film-coated

    Active substance Dosage
    levodopa 50 mg
    carbidopa 12.5 mg
    entacapone 200 mg

    ATC: N04BA03

    Manufacturer: Orion Corporation

  • The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from the ineffectiveness of previous levodopa dosing with dopa-decarboxylase inhibitors.

    Form: tablets, film-coated

    Active substance Dosage
    levodopa 100 mg
    carbidopa 25 mg
    entacapone 200 mg

    ATC: N04BA03

    Manufacturer: Orion Corporation

  • The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) that arise due to ineffective dosing during levodopa treatment with dopamine decarboxylase inhibitors.

    Form: tablets, film-coated

    Active substance Dosage
    levodopa 150 mg
    carbidopa 37.5 mg
    entacapone 200 mg

    ATC: N04BA03

    Manufacturer: Orion Corporation

  • The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from ineffective levodopa dosing with dopamine decarboxylase inhibitors.

    Form: tablets, film-coated

    Active substance Dosage
    levodopa 200 mg
    carbidopa 50 mg
    entacapone 200 mg

    ATC: N04BA03

    Manufacturer: Orion Corporation